Lataa...
Rituximab Treatment in Myasthaenia Gravis: Report of two paediatric cases
Myasthaenia gravis (MG) is an auto-immune disease involving the postsynaptic receptors in the neuromuscular junction. The condition is characterised by fatigable weakness of the skeletal muscles and is uncommon in children. Acetylcholinesterase inhibitors and immune-modifying medications are usually...
Tallennettuna:
| Julkaisussa: | Sultan Qaboos Univ Med J |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132519/ https://ncbi.nlm.nih.gov/pubmed/30210856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18295/squmj.2018.18.02.018 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|